This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Rehmannia glutinosa root
- DrugBank Accession Number
- DB14290
- Background
Rehmannia glutinosa root is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
- Type
- Biotech
- Groups
- Experimental
- Synonyms
- Di Huang
- Di Huang Root
- Digitalis Glutinosa Root
- Dihuang
- Fresh Earth Yellow Root
- Leuzea Uniflora Root
- Prepared Rehmannia Root
- Rehmannia Chinensis Root
- Rehmannia Chinensis Root Extract
- Rehmannia Glutinosa Processed Root
- Rehmannia Glutinosa Root Extract
- Rehmannia Glutinosa Root Tuber
- Rehmannia Glutinosa Root With Rhizome
- Rehmannia Root
- Rehmanniae Glutinosa Conquitae Radix
- Rehmanniae Preparata Radix Et Ehizoma
- Rehmanniae Radix
- Rehmanniae Radix Praeparata
- Rehmanniae Rhizoma Viridis
- Sheng Di Huang
- Shu Di Huang
- Shu Di Huang Root
- Shudihuang
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Over the Counter Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Chun-Shim Haedoksan Powder 5 g/100g Oral Hamabio Co., Ltd. 2013-07-08 Not applicable US 
- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Acne Control Essence Rehmannia glutinosa root (2 g/100g) + Octinoxate (5 g/100g) + Scutellaria baicalensis root (2 g/100g) + Zinc oxide (5 g/100g) Cream Topical Shenzhen Rongchuang Zhiyuan Industrial Co., Ltd. 2020-09-03 Not applicable US - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Chun-Shim Haedoksan Rehmannia glutinosa root (5 g/100g) Powder Oral Hamabio Co., Ltd. 2013-07-08 Not applicable US
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 1BEM3U6LQQ
- CAS number
- Not Available
References
- General References
- Not Available
- External Links
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Completed Treatment Central Precocious Puberty (CPP) 1 2 Recruiting Treatment Age Related Hearing Loss / Hearing Disorders and Deafness / Presbyacusis 1 2 Unknown Status Health Services Research Postmenopausal Osteoporosis 1 1, 2 Not Yet Recruiting Prevention Coronavirus Disease 2019 (COVID‑19) / Herbal Medicine 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Cream Topical Powder Oral 5 g/100g - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at July 05, 2018 17:13 / Updated at June 12, 2020 16:53